NON-CYSTIC FIBROSIS BRONCHIECTASIS
Clinical trials for NON-CYSTIC FIBROSIS BRONCHIECTASIS explained in plain language.
Never miss a new study
Get alerted when new NON-CYSTIC FIBROSIS BRONCHIECTASIS trials appear
Sign up with your email to follow new studies for NON-CYSTIC FIBROSIS BRONCHIECTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lung disease treatment opens for early access
Disease control APPROVED_FOR_MARKETINGThis program provides early access to brensocatib for adults with non-cystic fibrosis bronchiectasis who completed a previous clinical trial. Participants take a daily tablet to help control their chronic lung condition. The goal is to continue managing the disease while the trea…
Matched conditions: NON-CYSTIC FIBROSIS BRONCHIECTASIS
Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New inhaled treatment tested to fight stubborn lung infections
Disease control OngoingThis early-stage study is testing the safety and initial effectiveness of a new inhaled nitric oxide treatment called RESP30X. It is for adults with a lung condition called non-cystic fibrosis bronchiectasis who have persistent, high levels of certain bacteria in their lungs. Par…
Matched conditions: NON-CYSTIC FIBROSIS BRONCHIECTASIS
Phase: PHASE1, PHASE2 • Sponsor: Thirty Respiratory Limited • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC